Docstoc

westclifsprngsmer09

Document Sample
westclifsprngsmer09 Powered By Docstoc
					I 'i rl

LABOR*TORY REPOfiT
, tN6.

FF
SEX: M S. l,t.D.

R E Q.# : G L 7355l. . 74 9 BECETVE D: / 2t / 07 1_2 F I EPORT E D: l_l0l_/ 08 O AREAIROUTE: 00 01 COMMENTfi: FASTING

19:13 06:55

PATIFN.I.: KAUWE, DA}IIEIJ AA Ei 3 0 Y D oB : 05/12/7? R!F]DH.: IJAVI, DARIUSE P H ON E; 7 1 -4 - 585 - 1842

SBCFC: 05930 PAGE: 1 LAVT, DARIUSH S- M.D.

r "503 so. coAs T D R .
SUITE ].O9 CCSTA MESA CA 92626

PT PH#: 401-225-0513

ADV}}ITAGE #380?788

& 2 ABS IMMTINOBLOT HIV-1 Hrv-1 IgG ABS -IB gp16 0/ 1?0

p 6s pss
Y'r\
}-4*

I

gp4l. p40 p31 p24 P18
HIV_1 I$iTERPRETATIVE

*POgITIVE *PRESENT ABSENT ABSENT ABSENT *PRESEMT *PRESE}TT *PA"ESENT *PRESENT *P.RESE}NT
IQRITERIA :

NEGATIVE ABSENT ABSENT ABSENT ABSENT ABSENT ASSENT AESENT ABSENT AASENT

AE least two bands ;Ere$ent of ; g p l- 6 0 /12 D, gp41 ,, ;or pZ+ Any pattern of one lqr more bands presenL t,hat, dogq noL meeE Ehe criE,eria for posiitive
No bands present .
:!

P o s it iv e Indet,ermj-naE,e
Negat,ive

.i

HIv-z ABS -IB gpi05 p68 ps8
p55

i I ,.,i : i
! ,i

NEGATIVE A^BSENT AESENT ABSENT
AESENT

p3t/34
p26

, I
:

A B S E NT
ABSENT

p1s

ABSENT . I HTV-z INTERPRETATIVE.ftTTURTA' gp 1 0 5 plu s p26 or p.3:,,A /3q p 5 8 / 5 8 1 5 s or Any pat.t.ern of sigrii.ficant bands (15,
26, 31"/34, 69 qq :-05) that positive, fic-..a meet criteria. No significant bandsl.
.l

NEGATTVE ASSENT ABSENT ABSENT ABSENT ABSENT ABSENT ABSENT P o s it iwe
IndeterminaLe NegaLive

does not

immunoblot, ;tesEing is more specific than initiat EIA Confirmatory EIA resulti slrould be fo11or,,'ed-up screening; however, discrepant indj-cated. or repeated as cLinicallly fhis information is prdtlcted
'j

by various

statre laws specific

to

,
YESTCLIFF {EDICAL
mr!ttn Dt/

(,Contirur'edon Next Page) i
202{!N.mtcfinan, Str.A

rNLEssorHEBWrsE ALL TNDTCATED TEsrs wEREpenpdqueu er 1921E.orER RD.,sre r00,SANTA ANA.cA geros-szoo
A. 1821E. DyerRd.,Ste" 100 ' : lt,

B .ABORA,TORIES

SaEh CA Ana. 92705-5700 $anBeffirdkm. 9t484 CA cr3-9505 T2+3Sm I (8r9} {8001 {r0s}{75{[s5 Rd, J. 9?35 Wlshir8 36tHos$tal srau2 BM.,Sb.219
t{e,{Eon 8€nch, 32663 CA

Esverly cA90210 Htils,

LABOHATOHYDIRECTORS Torrrnca Sle.240 D.$- Harringlon,M.D. WilliarnTemple,h,t.O H. 4201 6lvd., pA'rHoLoclsTs Torrance, 9lFffl CA {$qFa.|558 M-D. EugenePeock, M.r ArthurWilliams, L 44725 SL SrdL24$ l{hn Pra\E€na M,O. Y€tur, GA LanEasls[ 93504 Mtt m^.lfstr /attutn?

R T\/

I

WEgJffiLIFF
MEDr L\?DRtloRrEs, cAL rNc.
ffEQ.#; Gt 73551?4 9 t2 RECEIVED: / 2L / 07 19 : 13 0l-l01/08 HEPORTED: 05:55 AREA/ROUTE: 00 01 FASTTNG COMMENTS: PATIENT: KAUWB, DAlIfEt nsE: 30Y DOB: 05/t2/77 SEX: M ITAVI, DARISSH S , }1. D. H*E DFt.: PtrlONr: 7]-4-585-1842

LABOR*TORY REPOHT

? SRCFC: 05930 PAGE: LAVI, DARIUSH S. M.D. 1503 SO. COAST DR. SUTTE 1O9 cosTA MESA CA 92625 ADVAT{:rAGE#3807788

P T P H# : 4 A l-2 2 5 -0 5 1 3
client and, location without the patient's permitted by law.

irl ,surch cases, be further canrot disclosed specific con.sent, or as otherwise written I i

The performanee characL$rj.sties of one or more of the assays. in this panel were establishedi{hrough validation by Specialty Laboratories, and no approval- is regrir{r€:d by the U.S. Food and Drug Administration purposes. are,rJsed for clinical They should not {FDA). These tests be regarded as investigaitional or for research. Specialty Laboratories is regulated under theiClj.nical Laboratory Improvement Amendments of 1988 {"CLIA") as gu4lified Eo perform high complexity cl-inical

t e s I in g .

I
't
il

.1 .i il
;l ..j

:i
.t 'I i

:l

I
ii

'I

$t
,i

'; {**.r

;i

End of FINAL Report. ***)

UNLESS WERE PERFU,NMED 1821E. DYEFRO., OTHEF.WISE INDICATES TESTS ALL AT STE.lm, S*NII ANA,cA 927!5.5700 TABORATORY DIRESK}FS ' A. 1821 0yerfid..Sle 1tF E. H, 202t1 iilatennan, A !1. St!. 4201 Tonarco 8fut, Sta240 D.S. Harringlon, M.D. WilliamTemple, M. WESTCLIFF S'atilaAm, 9270$5700 i CA San Bermdiru, 924& CA TorraREB,901i03 C PATHOLOGISTS MEDICAL ($r0!5at,0553 {m0}373-S5lE/{l|0)?2r-3SE {9891.75-C[Eri AnhurWilliarns, M.D. Er-rgone Pooock, tr ,l{725l{th St. Suib?{0 Rd., 222 .' , J. 9735 Wilshirg Sb.219 SlvdLABORATORIES B 361HEpital Ste. Pravg€na Yetur, M-D.
$_..--r a_i^r ^r mccr o_,.a, unl. Fi 6atln I rnada, I'lA Ot{u

wE\k/rFF
MEDTCAL L\rRVoRrEs, rNc.
R EQ.# : G 1 7355L7 4 9 R EC EfV E D: L2/ 2I / O ' t gL FTEPOFTTED: / OL / Oe AREtuHOUTE: 00 01 COMMENTS: FASTING 1 9 :1 3 O6 : 4 4

REPORT LAEORATORY

pAf{er.rr: KAItwE, DAI{rErr eGd: 30Y DO B : o =/ t z / t t SEX: M n{q on.: rJAvr, DARrusH g. M. D. pil9Ne: ?14 -5 8 5 -l-8 4 2
i

SF{CFCr 0593 0 PAGE: 3 LAVr, DA.R'TUSH S, M.D. 1503 SQ. COAST DR. SUITE ]-09 COSTA MESA CA 92525 ADVATVTAGE #3807788
NORMAL RANGE

P T P H# : 4 0 t -2 2 5 -0 5 1 3

CBC & AIITO DIFFEREMTIA&

wBe

RBC T{EMOGLOBIN HEMATOCRfT MCV MCH MCHC RDW PIJATELET COUNT SEGS LYMPHS MONOCY'IES EOSTNOPHILS BASOPHILS BANDS RPR HEPATITIS A TOTAIJ AT TIBO HAVAB TOTAL ANTIBODY ; i

9-9 4 .58 :r-.4.7 45.5
tt

31.4
JZ. J

13 .5

28 .3 6.5
ne

€D
@

4-O 4.20 14. 0 40. 0 no 27.O 31. 0 11.5 150 50.0

11.0 5.80 18. o 52.0 l-00

thou,/mm3 mi11,/mm3 gm/dl ? microns3

3s- o
3?.0 l_4.5 450 75.0 44.0

pg
gm/dl t thou/mm3 ? U

20.o o.0
a.u

r0.0
7.O z . CI 5 -0

z
? ? ?

0.0
NON-REACTIVE

0.0 0.0

NON-REACTIVE

NON-REACTIVE

NON-REACTIVE

for testing have not been established Assay performance char;i{tr:ristics of ner+borns, infants o1Yichildren- This assay was perfo:rmed using the Bayer Chemilumineseent, nreltttod. Assay performance characteristic leave rarit.h other w$qrr t,his assay is used in conjunction nol been established serological marker. manufacLurersr assays fgr, specifi-c H.A.V
HEPATITIS A AI*TIBODY rgll IIAVAB-IgM , ii

NON-REACTIVE

NON-REACTIVE

Aosay performance chara{t.erietics have noE been establlshed for tesEing of lchildren. This assay was performed using Che of newborns, infants Bayer Chemilurninescent, :qrefhod. Assay performance characteristic have noE been estrablished hrhe$.Lhis assay is used in coniunct,ion wich oLher manuf acE,urers' assays {dr specif ic itAv serological ilrarker . .n
;i

ir il |//
L A^- Li - ^- ^J ' I (Continued -on Next Page) f,/

ll I/ lhea

/\

fJ

)rt

WEHE JNLESS OTHERWTSE TNDIOATED ALLTESTS PEffFofiMED r82r E.trr€R RO.. AT ST€.lm, SAfrA ANA.CA92706.5700

I f$iigs*E'*'n'* ',{EDrcAL B. i'HTffiar,ffiiT,l1"0.Wil$in Htud.. J. 9735 Str.219 ,ABORATORIES
Sj,Ijjojgjjd;.lT;eg
' oa.$*t utb tt mJn

/VESTCLIIIF

R!,, A l82tE Dyey s!. !Q0

LASORATORY DIRECTORS

il. $taA , ' lt. 2040 Watsrman.

K 4201 Torrsflcs Elvd-Stc.240 D.S.Harington, M.D. William Temple, M,i Torrdncs, 90503 CA PATHOLOGISTS 3tt-r5t3 {3t01 ttllilliams, Arthur M.D. Eugene fucock, M. L 44725 St., 10lh SriteZdo PralrE€na M.O. Yetur.
t iner-, ca fi<ta

il
ji . ' .1 'i

LAEORATORY REPOR
4 SftCFC: 05930 PAGE: LAVI, DARIUSH S. M.D. 1503 SO. COAST DR. SUITE 109 COSTA MESA CA 92626 ADVA:flrAGE #3807788

.i ri ri

!

REQ.#: Gi 7355L749 L212I/ 07 19 : 13 RECEIVED: 01'/ REPORTEB: 0L/ Ag 05 :44 AREA/ROUTE: 00 0L COMMENTS:FASTING

ffAUWE, DANIEI., SEX: M OoB:05/L2/77 IrAVI DARIUSH S . !4. D, FEE DR.: ' Pt{oItE; 7L4-585r1842
P,{TlEhl-l-:

A QE : 30Y

,!

; i

P T P H# : 4 0 1 -2 2 5 -0 s 1 3

HEP. B SURFACE AI TIGEN HBsAg NON-REACTIVE NON-REACTTVE This assay was performp.d using Bayer Chemiluminometric method. Assay performance charabteristics have not been established when t.his with other manufactllrers' assay is used in conjuhption assays for l{BV serolog:y hbr for Eesting specific of newborns, infants or children.
i

HEP. B CORE A}{ITIBODY ANTI-HBc I NON-REACTIVE NON-REACTTVE charncLeristics Assay performance have not been esLablished for testing infants of newborns, oiri children. This assay was performed using the Bayer ChemiLuminescent: characterisEic have inr:t,hod. Assay performance w[en this noE been established assay i,s used in conjunction with oLher rnanuf acturers' assays lfg:r specif ic HBV serological marker. HEP. B ST'RT'ACE AT{TIBODY ANTT-HBs INTERPRETATION
'i

1 000.0 *R.EACTIVE

mlU,/mL NON-REACTTVE

**REFERENCE RANGE FOR [TEP. B SURFACE ANTTBODY: NONREACTIVg LESS THAN ].0.0 . ; REACTIVE GREATER THAN OR EQT]A]J TO 10. O
,,i

Adequate Response; tr: fmmunization: 4 6 1 --4 2 1 L997 lgr-18); {MMWR
Note; Assay assay specif 'tAssay tescing

>=10 mIU/mL

method. This assay was per:Eormed using Bayer CherniLuminescence performance have not been established when this charabl:erisLics with other manufacturers' is used in conjupifion assays for HBV serologic-a! markers. ic performance have not been est,ablished charbr:terj"stslcs for of newborns, in:f;rnts or chi-l-dren.
!!

f^

{Continued

on Next Page)

ANA.CA9270$,5700 WEREPEEFORIMED t 821 E, DrEF BD.,STE.| 00, SANTA AT ALL TNDTCATED TESTS UNLESS OTHEBT''ISE LABORATOHYDIRECTORS K 44,1Tornnce Sb.e40 D.S.Harrington,M.D. WilliamT€mp:e,|!l Ste. E.DyerRd,Sle.100 H. aPo t{. Watenmrl A Blvd., tr 1s21 WESTCLIFII . Ana. BsrnardiBo, 9?404 CA Torrance, 9(F0S saflra cA s2705-5700 i San DA PATHOLOGISTS pm).t*s865 38.S505{B{Sl no'3S60 MEDICAL , tatol Eili.0563 {800} M.D. ArlhurWilliams, EugenePocock, I ' ll,lllsldn J 9735 Elud. ?tg Sls. llHh B 361 Hospitet Sre L 4{725 St. SuitE 240 Rd,, 222 Praveena Yetur' LABORATORIES Nervoort Bavedy CA Hill$ S02t0 tancascr, 9:834 cA Beach. !P663 CA Y:^.. ,",,*

\\ \4 1 f

wEsffilfFF
MEDTcAL L\ifdff RrES, rNc.
REQ.#: c]- 73551-749 F|ECETVED: / 2tl 07 tZ 19: 13 REPOflTED: OL/ 0S 06 :44 OI/ AHEA/ROUTE: 00 01 COMMENTS: FASTING j: PATTE{-IT KAUWg, DAITIEI, AGE: 30Y DOB: 05/L2/77 SEX; M i nEF;qR.: IrAVf , DARIITSH S . ld, D. PHo,NE: 7L4-585-1842 , PT PH#: 401--225-0513

LABORATORY REPORT

SRCFG: 05930 PAGE: 5 LAVI, DARfUSH S. l"i, D.

1,503so. coAs T D R . SUTTETO9
COSTA MESA CA 92626 ADVAI{TAGE #380??88

HEPATITTS C AB HCV Antibody URINEI,YSIS COLOR APPEARANCE SPECTFIC GRAVITY URINE pH URINE PROTEIN URINE GLUCOSE URTNE KETONES URINE BI'JTRUBIN URINE tsIJOOD URTNE NTTRTTES UROBILTNOGEN LEUKOCYTES Hrv-7/2 PB SCREEN

NEGATIVE
YELLOW CI.EAR l -. 012

NEGATIVE

CLE.LR

6. 0 NEGATIVE NEGATTVE NEGATTVE
NEGATIVE NEGATTVE NEGATTVE 4.2 NEGATTVE *REACTTVE

r _. oo1 5.0
NEGATIVE NEGATIVE NEGATIVE NEGATJVE NEGATIVE NEGATIVE

1. 030 8.0

1.0

EU/ dL

NEGATIVE

NON-REACTTVE AnLibodies to HIV Lype-l,; :Lncluding group o and/or type 2 are det.ect,ed resulLs are by this Bayer Chemj-lumiltometric immunoassay. A]1 reactive repeated in duplicate. T$is result alone cannot be utilized as a diagnostic test until confifqect by Western Blot {Immunoblot) .

t{) u{,3*/

(rit* E nd of , F f NA I Re p o rt
{LESS OTTIERYWSE INDICA'IED ALLTESTS YVERE

***i

AT IE?I E. EryEF FID,,STE. 1OO, SAI{IA ANA, CA 91105.5700

E$TCLIFF EDICAL
{BORATORIES

A. 10?t E.DyBr Rd.,$te. 100 Ana CA927t)5-5708 Santa

(8ml s?3-95c5 7re$s0 , / {s{s}
i' ;J.

B. 361 Hosptra! sts. Rd., 2u ilerrDorl CA Beacti, Sm63

il. 2040 ftE[crmar, A SE, San Sarnardino, 92{lX CA {ss) fi5"6f65 Wilshirc Stt.?tg 9735 Bhd., fiilb. 90210 Belrerty CA

LABORATORYDIRECTOHS K- 4AI To(.enco $18.240 DS. Harington, M.D. WilliamTernple,M.D. tslvrl.. Tornncc, t0503 CA PATHOLOGISTS l3t0l 913.n563 Arthurtltilliams,M.D M EugefloFoco{r(, 0 L. 447?5 St, Srrtte l&n 240 **"* t:l:: tirsasrel cAfi,534 *o;D,^. 6A6,r


				
DOCUMENT INFO
Shared By:
Tags:
Stats:
views:12
posted:10/8/2009
language:English
pages:5